OAPI Broadens Its WIPO Agenda on Medicines and Geographical Indications
The African Intellectual Property Organization (OAPI) reported on 21 July that its participation in the 68th series of WIPO Assemblies produced a new cooperation agenda with practical implications for its member states. OAPI and the World Trade Organization agreed to develop a joint work plan on the use of TRIPS flexibilities, with attention to access to medicines, technology transfer and the review of relevant regulatory frameworks. The official account does not set out a detailed list of instruments. Compulsory licensing may form part of that policy toolkit, but its actual use will still depend on national legislation, administrative capacity and public-health priorities.
OAPI also discussed follow-up cooperation with several WIPO units, including WIPO GREEN, innovation support and capacity building, while linking geographical indications to projects for the protection and commercial development of natural and environmental resources. The combination is significant: regional IP policy is being framed less as a registration service alone and more as an instrument of industrial and development policy. The real test will be whether the announced work streams produce funded projects, clear institutional responsibilities and measurable benefits for medicine producers, local communities and GI users.



